Reacta Biotech raises £2.9m to scale up food allergy clinical diagnostics portfolio
The latest funding round was led by Praetura Ventures with follow-on equity from the Development Bank of Wales
Read More
Tag: clinical diagnostics
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
